Literature DB >> 6271840

Electrophysiologic properties of the cannabinoids.

S A Turkanis, R Karler.   

Abstract

The effects of the psychoactive cannabinoid delta 9-tetrahydrocannabinol (THC) and the nonpsychoactive cannabinoid cannabidiol (CBD) were investigated comparatively on electrically caused transcallosal cortical evoked responses, electrically induced limbic after discharges, photically evoked cortical afterdischarges, spontaneous cortical focal epileptic potentials, and spinal monosynaptic reflexes. In each system, THC produced central excitation; for example, the drug's responses ranged from enhancement of synaptic transmission to precipitation of frank convulsions. In addition to central nervous system stimulation, THC usually elicited depression; the qualitative character of the effect of the drug was dependent upon the dosage and the test system. In contrast to THC, cannabidiol generated no CNS excitation: it was either depressant or inert in these test systems. The results clearly demonstrate the complexity of the CNS properties of THC and the selectivity of the depressant properties of cannabidiol; moreover, the data illustrate the wide range of neuropharmacologic responses that potentially any cannabinoid can effect.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6271840     DOI: 10.1002/j.1552-4604.1981.tb02625.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

1.  Marijuana use and the risk of new onset seizures.

Authors:  J C Brust; S K Ng; A W Hauser; M Susser
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 2.  The Potential Proconvulsant Effects of Cannabis: a Scoping Review.

Authors:  Eric E Kaczor; Kevin Greene; Jennifer Zacharia; Laura Tormoehlen; Mark Neavyn; Stephanie Carreiro
Journal:  J Med Toxicol       Date:  2022-03-29

Review 3.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 4.  Cannabinoids for pediatric epilepsy? Up in smoke or real science?

Authors:  Francis M Filloux
Journal:  Transl Pediatr       Date:  2015-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.